Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,132.48
    +53.62 (+0.66%)
     
  • Bitcoin USD

    64,336.70
    +1,010.76 (+1.60%)
     
  • CMC Crypto 200

    1,328.87
    -67.66 (-4.85%)
     
  • S&P 500

    5,094.52
    +46.10 (+0.91%)
     
  • Dow

    38,250.70
    +164.90 (+0.43%)
     
  • Nasdaq

    15,868.08
    +256.32 (+1.64%)
     
  • Gold

    2,351.90
    +9.40 (+0.40%)
     
  • Crude Oil

    84.04
    +0.47 (+0.56%)
     
  • 10-Yr Bond

    4.6510
    -0.0550 (-1.17%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Merck or GlaxoSmithKline: Which Is Controlling Expenses Better?

Merck or GlaxoSmithKline: Which Is Controlling Expenses Better?

MRK or GSK: Which Is the Better Pharmaceutical Pick This Month?(Continued from Prior Part)Expenses guidance for 2019 On its fourth-quarter earnings conference call, Merck & Co. (MRK) guided for a low- to mid-single-digit YoY (year-over-year) rise